PROCEPT BioRobotics (PRCT) Consolidated Net Income (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Consolidated Net Income data on file, last reported at -$31.6 million in Q1 2026.

• Quarterly Consolidated Net Income fell 27.9% year-over-year to -$31.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$102.3 million (down 13.87% YoY) and the FY2025 annual result came in at -$95.6 million, down 4.55% from the prior year.
• Consolidated Net Income eased to -$31.6 million in Q1 2026 per PRCT's latest filing, from -$29.7 million in the prior quarter.
• Across five years, Consolidated Net Income topped out at -$17.2 million in Q1 2022 and bottomed at -$31.6 million in Q1 2026.
• The 5-year median for Consolidated Net Income is -$24.7 million (2025), against an average of -$24.0 million.
• The widest annual swing landed in 2023, when Consolidated Net Income plunged 65.75%; it then surged 32.58% in 2024.
• Tracing PRCT's Consolidated Net Income over 5 years: stood at -$24.9 million in 2022, then slipped by 10.07% to -$27.4 million in 2023, then surged by 32.58% to -$18.5 million in 2024, then plunged by 60.4% to -$29.7 million in 2025, then decreased by 6.69% to -$31.6 million in 2026.
• Per Business Quant, the three latest PRCT Consolidated Net Income figures stand at -$31.6 million (Q1 2026), -$29.7 million (Q4 2025), and -$21.4 million (Q3 2025).

Peer Comparison